Rubella vaccination programme in Malaysia

Analysis of a seroprevalence study in an antenatal clinic

Zamberi Sekawi, W. M N Muizatul, M. Marlyn, M. A Y Jamil, I. Ilina

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

In many developed countries, the incidence of rubella and congenital rubella syndrome (CRS) is considered to be negligible due to the availability of an effective vaccine. However, in Malaysia, several CRS cases are seen every year. This casts doubt on the effectiveness of the rubella vaccination programme. Very few seroprevalence studies were done over the years, making it difficult to discuss the effectiveness of the vaccination programme. The objective of this study is to determine the prevalence of rubella immunity among pregnant women attending antenatal clinics in a local teaching hospital. The hospital database on rubella immunity was assessed retrospectively from August 2001 to June 2002. A cross-sectional study of interviewed method as well as determination of rubella immunity by laboratory tests were carried out in July 2002, A total of 414 women were included, of whom 134 women were interviewed. The rubella immunity status was 92.3%. Based on this figure, rubella vaccination programme in Malaysia is a success despite the presence of CRS cases. Malaysia must ensure rubella vaccine coverage among target groups is high in order to minimise CRS cases.

Original languageEnglish
Pages (from-to)345-348
Number of pages4
JournalMedical Journal of Malaysia
Volume60
Issue number3
Publication statusPublished - 2005
Externally publishedYes

Fingerprint

Rubella
Malaysia
Seroepidemiologic Studies
Congenital Rubella Syndrome
Vaccination
Immunity
Rubella Vaccine
Program Evaluation
Developed Countries
Teaching Hospitals
Pregnant Women
Vaccines
Cross-Sectional Studies
Databases
Incidence

Keywords

  • Congenital Rubella Syndrome
  • Immunisation
  • Rubella
  • Seroprevalence
  • Vaccination
  • Vaccination Programme

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Sekawi, Z., Muizatul, W. M. N., Marlyn, M., Jamil, M. A. Y., & Ilina, I. (2005). Rubella vaccination programme in Malaysia: Analysis of a seroprevalence study in an antenatal clinic. Medical Journal of Malaysia, 60(3), 345-348.

Rubella vaccination programme in Malaysia : Analysis of a seroprevalence study in an antenatal clinic. / Sekawi, Zamberi; Muizatul, W. M N; Marlyn, M.; Jamil, M. A Y; Ilina, I.

In: Medical Journal of Malaysia, Vol. 60, No. 3, 2005, p. 345-348.

Research output: Contribution to journalArticle

Sekawi, Z, Muizatul, WMN, Marlyn, M, Jamil, MAY & Ilina, I 2005, 'Rubella vaccination programme in Malaysia: Analysis of a seroprevalence study in an antenatal clinic', Medical Journal of Malaysia, vol. 60, no. 3, pp. 345-348.
Sekawi, Zamberi ; Muizatul, W. M N ; Marlyn, M. ; Jamil, M. A Y ; Ilina, I. / Rubella vaccination programme in Malaysia : Analysis of a seroprevalence study in an antenatal clinic. In: Medical Journal of Malaysia. 2005 ; Vol. 60, No. 3. pp. 345-348.
@article{83e6fa5fb3bd467abbae6a0a5843c2ad,
title = "Rubella vaccination programme in Malaysia: Analysis of a seroprevalence study in an antenatal clinic",
abstract = "In many developed countries, the incidence of rubella and congenital rubella syndrome (CRS) is considered to be negligible due to the availability of an effective vaccine. However, in Malaysia, several CRS cases are seen every year. This casts doubt on the effectiveness of the rubella vaccination programme. Very few seroprevalence studies were done over the years, making it difficult to discuss the effectiveness of the vaccination programme. The objective of this study is to determine the prevalence of rubella immunity among pregnant women attending antenatal clinics in a local teaching hospital. The hospital database on rubella immunity was assessed retrospectively from August 2001 to June 2002. A cross-sectional study of interviewed method as well as determination of rubella immunity by laboratory tests were carried out in July 2002, A total of 414 women were included, of whom 134 women were interviewed. The rubella immunity status was 92.3{\%}. Based on this figure, rubella vaccination programme in Malaysia is a success despite the presence of CRS cases. Malaysia must ensure rubella vaccine coverage among target groups is high in order to minimise CRS cases.",
keywords = "Congenital Rubella Syndrome, Immunisation, Rubella, Seroprevalence, Vaccination, Vaccination Programme",
author = "Zamberi Sekawi and Muizatul, {W. M N} and M. Marlyn and Jamil, {M. A Y} and I. Ilina",
year = "2005",
language = "English",
volume = "60",
pages = "345--348",
journal = "Medical Journal of Malaysia",
issn = "0300-5283",
publisher = "Malaysian Medical Association",
number = "3",

}

TY - JOUR

T1 - Rubella vaccination programme in Malaysia

T2 - Analysis of a seroprevalence study in an antenatal clinic

AU - Sekawi, Zamberi

AU - Muizatul, W. M N

AU - Marlyn, M.

AU - Jamil, M. A Y

AU - Ilina, I.

PY - 2005

Y1 - 2005

N2 - In many developed countries, the incidence of rubella and congenital rubella syndrome (CRS) is considered to be negligible due to the availability of an effective vaccine. However, in Malaysia, several CRS cases are seen every year. This casts doubt on the effectiveness of the rubella vaccination programme. Very few seroprevalence studies were done over the years, making it difficult to discuss the effectiveness of the vaccination programme. The objective of this study is to determine the prevalence of rubella immunity among pregnant women attending antenatal clinics in a local teaching hospital. The hospital database on rubella immunity was assessed retrospectively from August 2001 to June 2002. A cross-sectional study of interviewed method as well as determination of rubella immunity by laboratory tests were carried out in July 2002, A total of 414 women were included, of whom 134 women were interviewed. The rubella immunity status was 92.3%. Based on this figure, rubella vaccination programme in Malaysia is a success despite the presence of CRS cases. Malaysia must ensure rubella vaccine coverage among target groups is high in order to minimise CRS cases.

AB - In many developed countries, the incidence of rubella and congenital rubella syndrome (CRS) is considered to be negligible due to the availability of an effective vaccine. However, in Malaysia, several CRS cases are seen every year. This casts doubt on the effectiveness of the rubella vaccination programme. Very few seroprevalence studies were done over the years, making it difficult to discuss the effectiveness of the vaccination programme. The objective of this study is to determine the prevalence of rubella immunity among pregnant women attending antenatal clinics in a local teaching hospital. The hospital database on rubella immunity was assessed retrospectively from August 2001 to June 2002. A cross-sectional study of interviewed method as well as determination of rubella immunity by laboratory tests were carried out in July 2002, A total of 414 women were included, of whom 134 women were interviewed. The rubella immunity status was 92.3%. Based on this figure, rubella vaccination programme in Malaysia is a success despite the presence of CRS cases. Malaysia must ensure rubella vaccine coverage among target groups is high in order to minimise CRS cases.

KW - Congenital Rubella Syndrome

KW - Immunisation

KW - Rubella

KW - Seroprevalence

KW - Vaccination

KW - Vaccination Programme

UR - http://www.scopus.com/inward/record.url?scp=33644810974&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33644810974&partnerID=8YFLogxK

M3 - Article

VL - 60

SP - 345

EP - 348

JO - Medical Journal of Malaysia

JF - Medical Journal of Malaysia

SN - 0300-5283

IS - 3

ER -